Apogee Therapeutics Common Stock Market Value
| APGE Stock | 67.78 1.53 2.21% |
| Symbol | Apogee |
Will Biotechnology sector continue expanding? Could Apogee diversify its offerings? Factors like these will boost the valuation of Apogee Therapeutics. If investors know Apogee will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apogee Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Apogee Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Apogee Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Apogee Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Apogee Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apogee Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Apogee Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Apogee Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Apogee Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Apogee Therapeutics.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Apogee Therapeutics on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Apogee Therapeutics Common or generate 0.0% return on investment in Apogee Therapeutics over 90 days. Apogee Therapeutics is related to or competes with Centessa Pharmaceuticals, Xenon Pharmaceuticals, Ascentage Pharma, Ultragenyx, Celcuity LLC, Zai Lab, and CG Oncology. Apogee Therapeutics is entity of United States More
Apogee Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Apogee Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Apogee Therapeutics Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.25 | |||
| Information Ratio | 0.0771 | |||
| Maximum Drawdown | 23.21 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 5.32 |
Apogee Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apogee Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Apogee Therapeutics' standard deviation. In reality, there are many statistical measures that can use Apogee Therapeutics historical prices to predict the future Apogee Therapeutics' volatility.| Risk Adjusted Performance | 0.087 | |||
| Jensen Alpha | 0.2566 | |||
| Total Risk Alpha | 0.0692 | |||
| Sortino Ratio | 0.0774 | |||
| Treynor Ratio | 0.339 |
Apogee Therapeutics February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.087 | |||
| Market Risk Adjusted Performance | 0.349 | |||
| Mean Deviation | 2.17 | |||
| Semi Deviation | 2.86 | |||
| Downside Deviation | 3.25 | |||
| Coefficient Of Variation | 1014.99 | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.67 | |||
| Information Ratio | 0.0771 | |||
| Jensen Alpha | 0.2566 | |||
| Total Risk Alpha | 0.0692 | |||
| Sortino Ratio | 0.0774 | |||
| Treynor Ratio | 0.339 | |||
| Maximum Drawdown | 23.21 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 5.32 | |||
| Downside Variance | 10.59 | |||
| Semi Variance | 8.21 | |||
| Expected Short fall | (2.40) | |||
| Skewness | (0.26) | |||
| Kurtosis | 4.1 |
Apogee Therapeutics Backtested Returns
At this point, Apogee Therapeutics is very steady. Apogee Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0389, which signifies that the company had a 0.0389 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Apogee Therapeutics Common, which you can use to evaluate the volatility of the firm. Please confirm Apogee Therapeutics' Risk Adjusted Performance of 0.087, downside deviation of 3.25, and Mean Deviation of 2.17 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%. Apogee Therapeutics has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.92, which signifies possible diversification benefits within a given portfolio. Apogee Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Apogee Therapeutics is expected to follow. Apogee Therapeutics right now shows a risk of 3.04%. Please confirm Apogee Therapeutics total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Apogee Therapeutics will be following its price patterns.
Auto-correlation | -0.67 |
Very good reverse predictability
Apogee Therapeutics Common has very good reverse predictability. Overlapping area represents the amount of predictability between Apogee Therapeutics time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Apogee Therapeutics price movement. The serial correlation of -0.67 indicates that around 67.0% of current Apogee Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.67 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 43.89 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Apogee Therapeutics is a strong investment it is important to analyze Apogee Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apogee Therapeutics' future performance. For an informed investment choice regarding Apogee Stock, refer to the following important reports:Check out Apogee Therapeutics Correlation, Apogee Therapeutics Volatility and Apogee Therapeutics Performance module to complement your research on Apogee Therapeutics. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Apogee Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.